Cancer News and Research

Latest Cancer News and Research

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.

26 Apr 2010

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

26 Apr 2010

Researchers synthesize metal compounds that can be effective in treatment of cancer

Scientists from Bochum have managed to accurately determine the location of metal complexes within living cancer cells using Raman microscopy. The researchers have thus gained new insights into the mechanism of action of metal-containing drugs, to which they ascribe great potential capacities, e.g. in the treatment of cancer.

26 Apr 2010

Bowel cancer screening programme launched in Northern Ireland

The bowel cancer screening programme, which detects early signs of the disease, has been launched in Northern Ireland.

26 Apr 2010

New reprogramming strategies needed for production of iPSCs: Study

Scientists may be one step closer to being able to generate any type of cells and tissues from a patient's own cells. In a study that will appear in the journal Nature and is receiving early online release, investigators from the Massachusetts General Hospital Center for Regenerative Medicine (MGH-CRM) and the Harvard Stem Cell Institute (HSCI), describe finding that an important cluster of genes is inactivated in induced pluripotent stem cells (iPSCs) that do not have the full development potential of embryonic stem cells.

26 Apr 2010

Mothers with preeclampsia at reduced risk of developing breast cancer

Preeclampsia is a high blood pressure syndrome in pregnant mothers that is caused when the blood supply in the placenta of the developing baby is restricted. The blood-deprived placenta releases factors that cause the raise in blood pressure in the mother. Doctors have to monitor these women closely and they may be forced to deliver the baby early to protect the mother and the baby. Most women's blood pressure returns to normal levels after they deliver the placenta.

26 Apr 2010

Negotiations break off between TUH and PASNAP

Negotiations broke off early Monday morning between Temple University Hospital and the Pennsylvania Association of Staff Nurses & Allied Professionals after sessions on Saturday and an over 18-hour session Sunday into Monday.

26 Apr 2010

Electronic primary care records can help identify untreated patients at high risk of cardiovascular disease

Using routine data from electronic patient records to select individuals at high risk of developing heart disease, rather than screening all adults aged between 40 and 74 years of age, is just as effective at saving lives but will be cheaper to run, according to research published on bmj.com today.

26 Apr 2010

DeCODE scientists discover common SNPs that increase number of CPD and risk of lung cancer

Cigarette smoking is a major cause of illness and death worldwide. But it is a complex behavior, and how much people smoke, how hard they find it to quit, and the impact of long-term smoking on health varies greatly among individuals. A substantial portion of this variability is genetic. Two years ago, deCODE discovered the first common, single-letter variation in the sequence of the human genome, on chromosome 15q25, associated with nicotine addiction and risk of lung cancer.

26 Apr 2010

Symphogen's Sympress II technology demonstrates cost-effective single batch production of rpAb

Symphogen A/S today announced the publication of data in the March 20, 2010 online edition of Molecular Biotechnology by Nielsen LS et al. [epub ahead of print] demonstrating the ability of its Sympress II technology to enable cost-effective production of recombinant polyclonal antibodies (rpAb) and antibody mixtures with batch-to-batch consistency that the Company believes could supply drug product for large indications such as cancer and infectious disease.

26 Apr 2010

Report shares what women need to know and what women can do

Lung Cancer Alliance hailed today's release of "Out of the Shadows: Women and Lung Cancer," a groundbreaking report issued by the Mary Horrigan Connors Center at Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School.

26 Apr 2010

Mirina closes Versant led Series A-1 financing

Mirina Corporation, a privately held biotechnology company focused on the generation of novel microRNA (miRNA) therapeutics with improved properties, announced today that it has closed a Series A-1 financing. The round was led by new investor Versant Ventures. Previous investors Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital also participated in the round. In conjunction with this financing, Brian Atwood, Managing Director of Versant Ventures, will join the Board of Directors.

26 Apr 2010

New method helps study interactions needed for formation of lipopolysaccharides

Scientists have combined chemistry and biology research techniques to explain how certain bacteria grow structures on their surfaces that allow them to simultaneously cause illness and protect themselves from the body's defenses.

26 Apr 2010

Chokeberry extract reduces weight gain in insulin-resistant animals

Chokeberry bushes have for centuries been residents of eastern deciduous forests where their bright red and dark purple fruits continue to be favorite snacks of local bird species. Native Americans have also traditionally eaten dried chokeberries and prepared teas from parts of the plant, and several domesticated varieties now grace contemporary lawns and gardens from coast to coast.

26 Apr 2010

New key-hole bowel surgery for cancer with only four days hospital stay

Major bowel cancer surgery usually takes days to heal. In a new technique developed by Tasmanian surgeons, the recovery time for such surgeries can be halved.

26 Apr 2010

Successful full face transplant in a 22 hour long operation: Barcelona

In a recent development a team of 30 Spanish surgeons have succeeded in a World’s first full face transplant. The patient had accidentally injured a large part of his face with a shotgun five years ago. This had left him disfigured an unable to breathe, swallow or talk properly. He has undergone nine unsuccessful operations before this operation was planned. In this operation he received the whole of his facial skin, muscles, nose, lips, teeth and cheek bones from a donor in a 22 hour operation at the Vall d'Hebron University Hospital on 20th March. He is on his way to recovery now. This is not the first face transplant but the first full face transplant and also the most complex of its kind.

26 Apr 2010

Ethnic differences in genetic factors may affect susceptibility to development of breast cancer

A new study finds that factors known to increase the risk of breast cancer among white women have less influence in Hispanic women. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that research is needed to evaluate how breast cancer risk factors differ among ethnic and racial populations.

26 Apr 2010

Three genetic regions associated with cigarette smoking

A team of scientists has used data from genome-wide association studies to identify genetic variants associated with key smoking behaviors that have a significant impact on health.

26 Apr 2010

Northwest Community Hospital's new $250M, nine-story addition set to open on May 1

Northwest Community Hospital in Arlington Heights becomes one of the biggest, busiest and most advanced hospitals in Illinois with a $250 million addition set to formally open May 1.

26 Apr 2010

High nitrate concentrations in drinking water are a potential hazard to human health

A new study exploring the growing worldwide problem of nitrogen pollution from soils to the sea shows that global ratios of nitrogen and carbon in the environment are inexorably linked, a finding that may lead to new strategies to help mitigate regional problems ranging from contaminated waterways to human health.

26 Apr 2010

Cancer News and Research

Latest Cancer News and Research

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

Researchers synthesize metal compounds that can be effective in treatment of cancer

Bowel cancer screening programme launched in Northern Ireland

New reprogramming strategies needed for production of iPSCs: Study

Mothers with preeclampsia at reduced risk of developing breast cancer

Negotiations break off between TUH and PASNAP

Electronic primary care records can help identify untreated patients at high risk of cardiovascular disease

DeCODE scientists discover common SNPs that increase number of CPD and risk of lung cancer

Symphogen's Sympress II technology demonstrates cost-effective single batch production of rpAb

Report shares what women need to know and what women can do

Mirina closes Versant led Series A-1 financing

New method helps study interactions needed for formation of lipopolysaccharides

Chokeberry extract reduces weight gain in insulin-resistant animals

New key-hole bowel surgery for cancer with only four days hospital stay

Successful full face transplant in a 22 hour long operation: Barcelona

Ethnic differences in genetic factors may affect susceptibility to development of breast cancer

Three genetic regions associated with cigarette smoking

Northwest Community Hospital's new $250M, nine-story addition set to open on May 1

High nitrate concentrations in drinking water are a potential hazard to human health

Cancer Research - Second Edition eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in